Physioneal + Dianeal + Extraneal + Nutrineal

ApprovedCompleted
0 views this week 0 watching Active
Interest: 40/100
40
Hype Score

Development Stage

Pre-clinical
Phase 1
Phase 2
Phase 3
5
Approved
Indication / Disease

ESRD

Conditions

ESRD, Diabetes, CAPD, APD

Trial Timeline

Jan 1, 2008 → Jul 1, 2011

About Physioneal + Dianeal + Extraneal + Nutrineal

Physioneal + Dianeal + Extraneal + Nutrineal is a approved stage product being developed by Baxter for ESRD. The current trial status is completed. This product is registered under clinical trial identifier NCT00567489. Target conditions include ESRD, Diabetes, CAPD.

What happened to similar drugs?

3 of 7 similar drugs in ESRD were approved

Approved (3) Terminated (0) Active (4)

Hype Score Breakdown

Clinical
20
Activity
8
Company
12
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00567489ApprovedCompleted

Competing Products

17 competing products in ESRD

See all competitors
ProductCompanyStageHype Score
RoxadustatAstraZenecaPhase 3
40
DoravirineMerckApproved
43
MK-2060 + PlaceboMerckPhase 1
29
Induction therapy + Corticosteroids + EVR+rCNI + MPA+sCNINovartisApproved
43
Mycophenolic Acid (Myfortic)NovartisApproved
43
AvacopanAmgenPhase 1
29
[¹⁴C]EtelcalcetideAmgenPhase 1
29
apixabanBristol Myers SquibbPhase 2
35
ISIS 416858 + PlaceboBayerPhase 2
32
ISIS 416858 + PlaceboBayerPhase 2
32
10 GE XenokidneyUnited TherapeuticsPhase 1/2
36
GGTA1 KO ThymokidneyUnited TherapeuticsPhase 1/2
36
Dianeal + Physioneal + Extraneal + NutrinealBaxterPhase 3
37
Dianeal + Dianeal, Extraneal, NutrinealBaxterPhase 3
37
Acellular Tissue Engineered Vessel (ATEV)HumacytePhase 3
37
Soluble Ferric Pyrophosphate + Soluble Ferric Pyrophosphate + Soluble Ferric Pyrophosphate + Soluble Ferric PyrophosphateRockwell MedicalPhase 2
25
soluble ferric pyrophosphate (SFP)Rockwell MedicalPre-clinical
8